title: EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.
abstract: Epidermal growth factor receptors (EGFR) contribute to colonic tumorigenesis in experimental models of colon cancer. We previously showed that EGFR was also required for colonic tumor promotion by Western diet. The goal of this study was to identify EGFR-regulated microRNAs that contribute to diet-promoted colonic tumorigenesis. Murine colonic tumors from Egfr(wt) and hypomorphic Egfr(wa2) mice were screened using micro RNA (miRNA) arrays and miR-143 and miR-145 changes confirmed by Northern, real-time PCR, and in situ analysis. Rodent and human sporadic and ulcerative colitis (UC)-associated colon cancers were examined for miR-143 and miR-145. Effects of EGFR on miR-143 and miR-145 expression were assessed in murine and human colonic cells and their putative targets examined in vitro and in vivo. miR-143 and miR-145 were readily detected in normal colonocytes and comparable in Egfr(wt) and Egfr(wa2) mice. These miRNAs were downregulated in azoxymethane and inflammation-associated colonic tumors from Egfr(wt) mice but upregulated in Egfr(wa2) tumors. They were also reduced in human sporadic and UC colon cancers. EGFR signals suppressed miR-143 and miR-145 in human and murine colonic cells. Transfected miR-143 and miR-145 inhibited HCT116 cell growth in vitro and in vivo and downregulated G(1) regulators, K-Ras, MYC, CCND2, cdk6, and E2F3, putative or established targets of these miRNAs. miRNA targets Ras and MYC were increased in colonic tumors from Egfr(wt) but not Egfr(wa2) mice fed a Western diet. EGFR suppresses miR-143 and miR-145 in murine models of colon cancer. Furthermore, Western diet unmasks the tumor suppressor roles of these EGFR-regulated miRNAs.
authors.forename: Hongyan
authors.initials: H
authors.lastname: Zhu
authors.forename: Urszula
authors.initials: U
authors.lastname: Dougherty
authors.forename: Victoria
authors.initials: V
authors.lastname: Robinson
authors.forename: Reba
authors.initials: R
authors.lastname: Mustafi
authors.forename: Joel
authors.initials: J
authors.lastname: Pekow
authors.forename: Sonia
authors.initials: S
authors.lastname: Kupfer
authors.forename: Yan Chun
authors.initials: YC
authors.lastname: Li
authors.forename: John
authors.initials: J
authors.lastname: Hart
authors.forename: Kathleen
authors.initials: K
authors.lastname: Goss
authors.forename: Alessandro
authors.initials: A
authors.lastname: Fichera
authors.forename: Loren
authors.initials: L
authors.lastname: Joseph
authors.forename: Marc
authors.initials: M
authors.lastname: Bissonnette
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D001397:Azoxymethane / Q000494:pharmacology; D000068818:Cetuximab; D003093:Colitis, Ulcerative / Q000150:complications / Q000378:metabolism; D003110:Colonic Neoplasms / Q000209:etiology / Q000235:genetics / Q000378:metabolism*; D016264:Dextran Sulfate / Q000494:pharmacology; D004032:Diet / Q000009:adverse effects*; D015536:Down-Regulation; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D016193:G1 Phase / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D045325:HCT116 Cells; D006801:Humans; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D009374:Neoplasms, Experimental / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C543499:MIRN145a microRNA, mouse; D035683:MicroRNAs; C532884:MIRN143 microRNA, mouse; D016264:Dextran Sulfate; C541485:EGFR protein, mouse; D066246:ErbB Receptors; D001397:Azoxymethane; D000068818:Cetuximab